FDA Drug Application (021690) for ORTHO TRI-CYCLEN 21 by ORTHO MCNEIL PHARM

Back to FDA Applications sponsored by ORTHO MCNEIL PHARM

Application Number021690
Product Number001
FormTABLET; ORAL-21
Dosage0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameORTHO TRI-CYCLEN 21
Active IngredientETHINYL ESTRADIOL; NORGESTIMATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORGESTIMATE23


Back to FDA Applications sponsored by ORTHO MCNEIL PHARM